These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10974311)

  • 1. Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence.
    Popik P; Wróbel M; Nowak G
    Neuropharmacology; 2000 Sep; 39(12):2278-87. PubMed ID: 10974311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice.
    Wiley JL; Cristello AF; Balster RL
    Eur J Pharmacol; 1995 Dec; 294(1):101-7. PubMed ID: 8788421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A characterization of anxiolytic-like actions induced by the novel NMDA/glycine site antagonist, L-701,324.
    Kotlinska J; Liljequist S
    Psychopharmacology (Berl); 1998 Jan; 135(2):175-81. PubMed ID: 9497023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments.
    Paul IA; Nowak G; Layer RT; Popik P; Skolnick P
    J Pharmacol Exp Ther; 1994 Apr; 269(1):95-102. PubMed ID: 8169857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiolytic-like effects of NMDA/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats.
    Bertoglio LJ; Carobrez AP
    Psychopharmacology (Berl); 2003 Dec; 170(4):335-42. PubMed ID: 13680083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715).
    Layer RT; Popik P; Olds T; Skolnick P
    Pharmacol Biochem Behav; 1995 Nov; 52(3):621-7. PubMed ID: 8545484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiolytic effect of glycine antagonists microinjected into the dorsal periaqueductal grey.
    Matheus MG; Nogueira RL; Carobrez AP; Graeff FG; Guimarães FS
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):565-9. PubMed ID: 7862877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMDA-coupled periaqueductal gray glycine receptors modulate anxioselective drug effects on plus-maze performance.
    De Souza MM; Schenberg LC; de Pádua Carobrez A
    Behav Brain Res; 1998 Feb; 90(2):157-65. PubMed ID: 9521547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMDA receptor activation antagonizes the NMDA antagonist-induced antianxiety effect in the elevated plus-maze test in mice.
    Poleszak E; Serefko A; Szopa A; Wośko S; Dudka J; Wróbel A; Oniszczuk T; Wlaź P
    Pharmacol Rep; 2013; 65(5):1124-31. PubMed ID: 24399708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticonflict effects of a competitive NMDA receptor antagonist and a partial agonist at strychnine-insensitive glycine receptors.
    Przegaliński E; Tatarczyńska E; Dereń-Wesołek A; Chojnacka-Wójcik E
    Pharmacol Biochem Behav; 1996 May; 54(1):73-7. PubMed ID: 8728541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMDA/glutamate mechanism of magnesium-induced anxiolytic-like behavior in mice.
    Poleszak E; Wlaź P; Wróbel A; Fidecka S; Nowak G
    Pharmacol Rep; 2008; 60(5):655-63. PubMed ID: 19066411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of NMDA receptor complex in the anxiolytic-like effects of chlordiazepoxide in mice.
    Poleszak E; Socała K; Szopa A; Wróbel A; Szewczyk B; Kasperek R; Blicharska E; Nowak G; Wlaź P
    J Neural Transm (Vienna); 2011 Jun; 118(6):857-64. PubMed ID: 21298298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiolytic activity of glycine-B antagonists and partial agonists--no relation to intrinsic activity in the patch clamp.
    Karcz-Kubicha M; Jessa M; Nazar M; Plaznik A; Hartmann S; Parsons CG; Danysz W
    Neuropharmacology; 1997 Oct; 36(10):1355-67. PubMed ID: 9423923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats.
    Przegaliński E; Tatarczyńska E; Chojnacka-Wójcik E
    Neuropharmacology; 2000 Jul; 39(10):1858-64. PubMed ID: 10884566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological characterisation of the antagonist properties of two novel NMDA receptor glycine site antagonists, L-695,902 and L-701,324.
    Priestley T; Laughton P; Macaulay AJ; Hill RG; Kemp JA
    Neuropharmacology; 1996; 35(11):1573-81. PubMed ID: 9025105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some central effects of kynurenic acid, 7-chlorokynurenic acid and 5,7- dichloro-kynurenic acid, glycine site antagonists.
    Maj J; Rogóz Z; Skuza G; Kołodziejczyk K
    Pol J Pharmacol; 1994; 46(3):115-24. PubMed ID: 8000442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The NMDA/glycine receptor antagonist, L-701,324, produces discriminative stimuli similar to those of ethanol.
    Kotlinska J; Liljequist S
    Eur J Pharmacol; 1997 Jul; 332(1):1-8. PubMed ID: 9298919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of morphine dependence and withdrawal by glycine B site antagonists in rats.
    Kotlińska J
    Pharmacol Biochem Behav; 2001 Jan; 68(1):157-61. PubMed ID: 11274720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions.
    Trullas R; Skolnick P
    Eur J Pharmacol; 1990 Aug; 185(1):1-10. PubMed ID: 2171955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine.
    Paul IA; Layer RT; Skolnick P; Nowak G
    Eur J Pharmacol; 1993 Nov; 247(3):305-11. PubMed ID: 7905831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.